BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38285234)

  • 21. Circulation EBV Mir-Bart-7 Relating to Clinical Manifestation in Nasopharyngeal Carcinoma.
    Wardana T; Gunawan L; Herawati C; Oktriani R; Anwar S; Astuti I; Aryandono T; Mubarika S
    Asian Pac J Cancer Prev; 2020 Sep; 21(9):2777-2782. PubMed ID: 32986380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survival analysis of patients with advanced-stage nasopharyngeal carcinoma according to the Epstein-Barr virus status.
    Peng H; Chen L; Zhang Y; Guo R; Li WF; Mao YP; Tan LL; Sun Y; Zhang F; Liu LZ; Tian L; Lin AH; Ma J
    Oncotarget; 2016 Apr; 7(17):24208-16. PubMed ID: 27008701
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epstein-Barr virus and human papillomavirus serum antibodies define the viral status of nasopharyngeal carcinoma in a low endemic country.
    Simon J; Schroeder L; Ingarfield K; Diehl S; Werner J; Brenner N; Liu Z; Pawlita M; Pring M; Butt J; Ness A; Waterboer T
    Int J Cancer; 2020 Jul; 147(2):461-471. PubMed ID: 32279316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human papillomavirus and Epstein-Barr virus in nasopharyngeal carcinoma in a low-incidence population.
    Dogan S; Hedberg ML; Ferris RL; Rath TJ; Assaad AM; Chiosea SI
    Head Neck; 2014 Apr; 36(4):511-6. PubMed ID: 23780921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nasopharyngeal carcinoma patients from Norway show elevated Epstein-Barr virus IgA and IgG antibodies prior to diagnosis.
    Simon J; Brenner N; Reich S; Langseth H; Hansen BT; Ursin G; Ferreiro-Iglesias A; Brennan P; Kreimer AR; Johansson M; Pring M; Nygard M; Waterboer T
    Cancer Epidemiol; 2022 Apr; 77():102117. PubMed ID: 35121404
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical utility of circulating Epstein-Barr virus DNA analysis for the management of nasopharyngeal carcinoma.
    Fung SY; Lam JW; Chan KC
    Chin Clin Oncol; 2016 Apr; 5(2):18. PubMed ID: 27121878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epstein-Barr Virus in Nasopharyngeal Carcinoma of Guatemalan and Brazilian Patients.
    Rumayor Piña A; Dos Santos HT; Carlos R; Altemani A; de Almeida OP
    Int J Surg Pathol; 2017 Jun; 25(4):304-309. PubMed ID: 27881609
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Negative plasma Epstein-Barr virus DNA nasopharyngeal carcinoma in an endemic region and its influence on liquid biopsy screening programmes.
    Nicholls JM; Lee VH; Chan SK; Tsang KC; Choi CW; Kwong DL; Lam KO; Chan SY; Tong CC; So TH; Leung TW; Luk MY; Khong PL; Lee AW
    Br J Cancer; 2019 Oct; 121(8):690-698. PubMed ID: 31527689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epstein-Barr virus infection and nasopharyngeal carcinoma.
    Tsao SW; Tsang CM; Lo KW
    Philos Trans R Soc Lond B Biol Sci; 2017 Oct; 372(1732):. PubMed ID: 28893937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Updates on Epstein-Barr Virus (EBV)-Associated Nasopharyngeal Carcinoma: Emphasis on the Latent Gene Products of EBV.
    Ahmed N; Abusalah MAHA; Farzand A; Absar M; Yusof NY; Rabaan AA; AlSaihati H; Alshengeti A; Alwarthan S; Alsuwailem HS; Alrumaih ZA; Alsayyah A; Yean CY
    Medicina (Kaunas); 2022 Dec; 59(1):. PubMed ID: 36676626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence and mortality of nasopharyngeal carcinoma: interim analysis of a cluster randomized controlled screening trial (PRO-NPC-001) in southern China.
    Ji MF; Sheng W; Cheng WM; Ng MH; Wu BH; Yu X; Wei KR; Li FG; Lian SF; Wang PP; Quan W; Deng L; Li XH; Liu XD; Xie YL; Huang SJ; Ge SX; Huang SL; Liang XJ; He SM; Huang HW; Xia SL; Ng PS; Chen HL; Xie SH; Liu Q; Hong MH; Ma J; Yuan Y; Xia NS; Zhang J; Cao SM
    Ann Oncol; 2019 Oct; 30(10):1630-1637. PubMed ID: 31373615
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human papillomavirus may be common within nasopharyngeal carcinoma of Caucasian Americans: investigation of Epstein-Barr virus and human papillomavirus in eastern and western nasopharyngeal carcinoma using ligation-dependent polymerase chain reaction.
    Punwaney R; Brandwein MS; Zhang DY; Urken ML; Cheng R; Park CS; Li HB; Li X
    Head Neck; 1999 Jan; 21(1):21-9. PubMed ID: 9890347
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increasing incidence of Epstein-Barr virus-related nasopharyngeal carcinoma in the United States.
    Argirion I; Zarins KR; Ruterbusch JJ; Vatanasapt P; Sriplung H; Seymour EK; Rozek LS
    Cancer; 2020 Jan; 126(1):121-130. PubMed ID: 31524955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cigarette smoking increases the risk of nasopharyngeal carcinoma through the elevated level of IgA antibody against Epstein-Barr virus capsid antigen: A mediation analysis.
    Hsu WL; Chien YC; Huang YT; Yu KJ; Ko JY; Lin CY; Tsou YA; Leu YS; Liao LJ; Chang YL; Su JY; Liu Z; Wang CP; Terng SD; Hua CH; Lee JC; Yang TL; Kate Hsiao CH; Wu MS; Tsai MH; Liu MJ; Lou PJ; Hildesheim A; Chen CJ;
    Cancer Med; 2020 Mar; 9(5):1867-1876. PubMed ID: 31925935
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complementary determination of Epstein-Barr virus DNA load and serum markers for nasopharyngeal carcinoma screening and early detection in individuals at risk in Tunisia.
    Baizig NM; Morand P; Seigneurin JM; Boussen H; Fourati A; Gritli S; Oueslati Z; Touati S; Gamoudi A; Ben Abdallah M; El May M; El May A
    Eur Arch Otorhinolaryngol; 2012 Mar; 269(3):1005-11. PubMed ID: 21805179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sibship size, birth order and risk of nasopharyngeal carcinoma and infectious mononucleosis: a nationwide study in Sweden.
    Liu Z; Fang F; Chang ET; Adami HO; Ye W
    Int J Epidemiol; 2016 Jun; 45(3):825-34. PubMed ID: 25925268
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of Epstein-Barr virus genotypes and clinicohistopathological features of nasopharyngeal carcinoma between Guilin, China and Fukuoka, Japan.
    Zhou Y; Nabeshima K; Koga K; Aoki M; Hayashi H; Hamasaki M; Iwasaki H
    Oncol Rep; 2008 Jun; 19(6):1413-20. PubMed ID: 18497945
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retrospective analysis of oncogenic human papilloma virus and Epstein-Barr virus prevalence in Turkish nasopharyngeal cancer patients.
    Tatlı Doğan H; Kılıçarslan A; Doğan M; Süngü N; Güler Tezel G; Güler G
    Pathol Res Pract; 2016 Nov; 212(11):1021-1026. PubMed ID: 27640103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-Term Outcomes of Nasopharyngeal Carcinoma by Epstein-Barr Virus Status in the Chinese Population: A Multicenter Investigation.
    Xiong Y; Yuan M; Liu Z; Huang J; Bi J; Pi G; Li Y; Li Y; He H; Verma V; Tian S; Han G
    J Clin Med; 2023 Apr; 12(8):. PubMed ID: 37109338
    [No Abstract]   [Full Text] [Related]  

  • 40. Epidemiological analysis of nasopharyngeal carcinoma in the central region of Japan during the period from 1996 to 2005.
    Kimura Y; Suzuki D; Tokunaga T; Takabayashi T; Yamada T; Wakisaka N; Yoshizaki T; Murata H; Miwa K; Shoujaku H; Watanabe Y; Yamada N; Ito Y; Yuta A; Takeuchi K; Hosokawa S; Mineta H; Hasegawa Y; Fujimoto Y; Nakashima T; Fujieda S
    Auris Nasus Larynx; 2011 Apr; 38(2):244-9. PubMed ID: 20817430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.